Comparing Revenue Performance: Lantheus Holdings, Inc. or ACADIA Pharmaceuticals Inc.?

Lantheus vs. ACADIA: A Decade of Revenue Growth

__timestampACADIA Pharmaceuticals Inc.Lantheus Holdings, Inc.
Wednesday, January 1, 2014120000301600000
Thursday, January 1, 201561000293461000
Friday, January 1, 201617331000301853000
Sunday, January 1, 2017124901000331378000
Monday, January 1, 2018223807000343374000
Tuesday, January 1, 2019339076000347337000
Wednesday, January 1, 2020441755000339410000
Friday, January 1, 2021484145000425208000
Saturday, January 1, 2022517235000935061000
Sunday, January 1, 20237264370001296429000
Loading chart...

In pursuit of knowledge

Revenue Race: Lantheus Holdings vs. ACADIA Pharmaceuticals

In the dynamic world of pharmaceuticals, revenue growth is a key indicator of success. Over the past decade, Lantheus Holdings, Inc. and ACADIA Pharmaceuticals Inc. have been on a fascinating journey. From 2014 to 2023, Lantheus Holdings has consistently outperformed ACADIA Pharmaceuticals in terms of revenue. In 2023, Lantheus Holdings reported a staggering 1.3 billion USD, marking a 330% increase from 2014. Meanwhile, ACADIA Pharmaceuticals, despite a significant growth of over 6000% from 2014, reached 726 million USD in 2023. This comparison highlights Lantheus Holdings' robust growth trajectory, especially in recent years, where it nearly doubled its revenue from 2021 to 2023. As the pharmaceutical industry continues to evolve, these companies exemplify the diverse strategies and outcomes in revenue performance.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025